The Epidemiology of Nonalcoholic Fatty Liver Disease: A Global Perspective

被引：543

作者：

Lazo, Mariana ^{[2
,3
]}

Clark, Jeanne M. ^{[1
,2
,3
]}

机构：

[1] Johns Hopkins Univ, Dept Med, Baltimore, MD USA

[2] Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA

[3] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA

来源：

SEMINARS IN LIVER DISEASE | 2008年 / 28卷 / 04期

关键词：

Nonalcoholic fatty liver disease; NAFLD; epidemiology; risk factors;

D O I：

10.1055/s-0028-1091978

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Nonalcoholic fatty liver disease (NAFLD) is an increasingly recognized cause of liver disease in the United States and worldwide. With obesity being an important risk factor universally, NAFLD is now receiving greater attention and is regarded as a public health issue. In addition, as a result of an aging population and the improving control of other major causes of chronic liver disease, such as hepatitis C and hepatitis B, the burden of NAFLD is expected to increase in years to come. Prevalence estimates of this disease vary widely across populations because of differences in methods for diagnosis and/or definition. New strategies for the prevention, diagnosis, and management will be required to alter the course of this disease.

引用

页码：339 / 350

页数：12

共 140 条

[51]

GROUND KEU, 1984, AVIAT SPACE ENVIR MD, V55, P59

[52] Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease [J].

Guha, I. N. ;

Parkes, J. ;

Roderick, P. R. ;

Harris, S. ;

Rosenberg, W. M. .

GUT, 2006, 55 (11) :1650-1660

[53] Non-alcoholic steatohepatitis in type 2 diabetes mellitus [J].

Gupte, P ;

Amarapurkar, D ;

Agal, S ;

Baijal, R ;

Kulshrestha, P ;

Pramanik, S ;

Patel, N ;

Madan, A ;

Amarapurkar, A ;

Hafeezunnisa .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 (08) :854-858

[54] Magnetic resonance Spectroscopy of hepatic lipid content and associated risk factors in HIV infection [J].

Hadigan, Colleen ;

Liebau, James ;

Andersen, Rebecca ;

Holalkere, Nagaraj-Setry ;

Sahani, Dushyant V. .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 46 (03) :312-317

[55] Hepatic steatosis in liver transplant donors: Rare phenomenon or common feature of donor population? [J].

Halon, A ;

Patrzalek, D ;

Rabczynski, J .

TRANSPLANTATION PROCEEDINGS, 2006, 38 (01) :193-195

[56] The metabolic syndrome as a predictor of nonalcoholic fatty liver disease [J].

Hamaguchi, M ;

Kojima, T ;

Takeda, N ;

Nakagawa, T ;

Taniguchi, H ;

Fujii, K ;

Omatsu, T ;

Nakajima, T ;

Sarui, H ;

Shimazaki, M ;

Kato, T ;

Okuda, J ;

Ida, K .

ANNALS OF INTERNAL MEDICINE, 2005, 143 (10) :722-728

[57] Liver markers and development of the metabolic syndrome - The insulin resistance atherosclerosis study [J].

Hanley, AJG ;

Williams, K ;

Festa, A ;

Wagenknecht, LE ;

D'Agostino, RB ;

Haffner, SM .

DIABETES, 2005, 54 (11) :3140-3147

[58] Elevations in markers of liver injury and risk of type 2 diabetes - The insulin resistance atherosclerosis study [J].

Hanley, AJG ;

Williams, K ;

Festa, A ;

Wagenknecht, LE ;

D'Agostino, RB ;

Kempf, J ;

Zinman, B ;

Haffner, SM .

DIABETES, 2004, 53 (10) :2623-2632

[59] Prevalence and predictive factors of non-alcoholic steatohepatitis (NASH) in morbidly obese patients undergoing bariatric surgery [J].

Harnois, F ;

Msika, S ;

Sabaté, JM ;

Mechler, C ;

Jouet, P ;

Barge, J ;

Coffin, B .

OBESITY SURGERY, 2006, 16 (02) :183-188

[60] The characteristics and natural history of Japanese patients with nonalcoholic fatty liver disease [J].

Hashimoto, E ;

Yatsuji, S ;

Kaneda, H ;

Yoshioka, Y ;

Taniai, M ;

Tokushige, K ;

Shiratori, K .

HEPATOLOGY RESEARCH, 2005, 33 (02) :72-76

← 1 2 3 4 5 6 7 8 9 10 →